- Home/In The News/Press
1
May2015
RELEASE
KRS Global Biotechnology, Inc. Announces the Compounded Service of Nitroglycerin.
FDA registered and inspected 503B Human Outsourcing Facility, KRS Global Biotechnology, Inc. who specializes in the preparation of drugs no longer commercially available or in short supply, announces today that they are providing the service of compounded nitroglycerin. BOCA RATON, FL., 7 July 2014 – KRS Global Biotechnology, Inc. is pleased to announce that it […]
1
May2015
RELEASE
KRS Global Reveals That It Has Produced Sterile Injectables in Closed Vial System Since Q3 of 2014
Boca Raton, FL: KRS Global Biotechnology (KRS-GBT), FDA Registered Human Drug Outsourcing Facility under Section 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act), is excited to reveal closed-system automation already in place. FOR IMMEDIATE RELEASE Colanar Modular Syringe, Vial and Cartridge Filling System – FSM Boca Raton, FL., November 18, 2014 – […]
23
April2015
RELEASE
KRS Global Biotechnology, Inc. Announces FDA Registration and Inspection of Becoming an Outsourcing Facility (via section 503B); Compounding Quality Act
KRS Global Biotechnology, Inc. a specialty pharmacy preparing drugs no longer commercially available or in short supply announces today that they have become a registered Outsourcing Facility under the new Compounding Quality Act. BOCA RATON, FL., 14th April, 2014 – KRS Global Biotechnology, Inc. is pleased to announce that it has been recognized as a […]